FDA Issues Complete Response Letter for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application

View Full Size 

Download

• Full Size JPEG, 1448x450, 243.8 KB
• Small JPEG, 300x93, 41.8 KB
• Preview JPEG, 144x45, 23.6 KB
• Thumbnail JPEG, 120x37, 20.5 KB